• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Environ Health Sci Eng . Aerosolized SARS-CoV-2 exposure assessment: dispersion modeling with AERMOD

tetano

Editor, Senior Moderator
J Environ Health Sci Eng


. 2021 Jan 12;1-9.
doi: 10.1007/s40201-020-00602-9. Online ahead of print.
Aerosolized SARS-CoV-2 exposure assessment: dispersion modeling with AERMOD


Mostafa Rezaali[SUP] 1 [/SUP], Reza Fouladi-Fard[SUP] 2 [/SUP]



Affiliations

Abstract

COVID-19 is now a pandemic and the knowledge gap on SARS-CoV-2, i.e., the COVID-19 disease agent, dispersion persists. The US Centers for Disease Control and Prevention suggests fomites may not be the main route through which the novel coronavirus spreads. Supporting the same view, the latest the World Health Organization report recommends wearing masks for every individual in public, highlighting the transmission through the air. In the current study AERMOD, one of the most validated and tested models suggested by the USEPA, is used to model SARS-CoV-2-laden PM[SUB]10[/SUB] in a hypothetical outdoor environment. Multiple scenarios including particle size, wind speed, source height variations as well as and combined scenarios were modeled to estimated how exposure risk changes with the above-mentioned variables. The results reveal that wind speed majorly narrows infectious plume rather than transferring the peak concentration. The particle size variation indicated that small particles, i.e.,0.01 - 2.5 μm, could reach more than 9 m away from the source in concentration range of 10 - 20 (μg/m [SUP]3[/SUP]). On the other hand, source height contributes to peak plume shift rather than dispersing the infected particles. This idea was further studies by using combined scenarios which indicated height difference can impact peak plume displacement rather than wind speed. In the worst-case scenario, the results indicate that the virus-laden particles can travel outdoors more than 8 m away from an infected source. The video output of the model results clearly shows the dynamic of viral peak shifts in several scenarios. The results also indicate that in specific conditions the airborne SARS-CoV-2 can be transported to 9 m away from the source. These findings can be useful for individuals as well as decision-makers to mitigated exposure risk in real-world conditions.
Supplementary information: The online version contains supplementary material available at 10.1007/s40201-020-00602-9.

Keywords: AERMOD; COVID-19; Outdoor exposure; SARS-CoV-2; Transmission through the air; Virus-laden particles.
 
Back
Top Bottom